"We are thrilled to introduce MOUNJARO, which represents the first new class of type 2 diabetes medication introduced in almost a decade and embodies our mission to bring innovative new therapies to the Australian diabetes community," said Tori Brown, the general manager of Eli Lilly Australia. …
Lilly goes for private launch of first-in-class diabetes therapy
August 24, 2023 Latest NewsBioPharma
Latest Video
New Stories
-
New Zealand to streamline access to ADHD treatments
June 26, 2025 - - Latest News -
CLEO strengthens FDA submission following Access to globally recognised Biobank
June 25, 2025 - - Australian Biotech -
Leukaemia Foundation calls for urgent action to address diagnosis and treatment gaps
June 25, 2025 - - Latest News -
QBiotics' candidate produces strong efficacy result in soft tissue sarcoma trial
June 25, 2025 - - Latest News -
Noxopharm says clinical trial recruitment progressing rapidly
June 25, 2025 - - Australian Biotech -
AusBiotech leads global engagement to strengthen Australia's life sciences sector
June 25, 2025 - - Australian Biotech -
NT doctors want action as whooping cough cases soar
June 25, 2025 - - Latest News